| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-48211 | |||
| Azide and BSA Free | NBP3-11564 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-59617 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44825 | |||
| Azide and BSA Free | NBP2-34548-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-48180 | |||
| Azide and BSA Free | NBP3-11504 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44535 | |||
| Azide and BSA Free | NBP2-34543-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47853-0.1mg | |||
| IHC-Prediluted | NBP2-48303 | |||
![Western Blot: ATRX Antibody (4212) [NBP2-43599] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with ATRX antibody [GT4212].](http://images.novusbio.com/fullsize/ATRX-Antibody-4212-Western-Blot-NBP2-43599-img0005.jpg "<b>Genetic Strategies Validation. </b>Western Blot: ATRX Antibody (4212) [NBP2-43599] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with ATRX antibody [GT4212].")
![<b>Genetic Strategies Validation. </b>Western Blot: ATRX Antibody (4212) [NBP2-43599] - Analysis of A. 30 ug Neuro2A whole cell lysate/extract B. 30 ug C8D30 whole cell lysate/extract C. 30 ug BCL-1 whole cell lysate/extract 5 % SDS-PAGE ATRX antibody [4212] dilution: 1:500.](http://images.novusbio.com/fullsize/ATRX-Antibody-4212-Western-Blot-NBP2-43599-img0001.jpg)
![ATRX antibody [GT4212] detects ATRX protein at nucleus by immunofluorescent analysis.Sample: HeLa cells were fixed in 4% paraformaldehyde at RT for 15 min.Green: ATRX protein stained by ATRX antibody [GT4212] (NBP2-43599) diluted at 1:500.Blue: Hoechst 33342 staining.](http://images.novusbio.com/fullsize/nbp2-43599_mouse-monoclonal-atrx-antibody-4212-immunocytochemistry-immunofluorescence-2611202518224311.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 8/18 Antibody (SPM141) [NBP2-44926] - Human Lung Carcinoma stained with Cytokeratin 8/18 Monoclonal Antibody (SPM141).](http://images.novusbio.com/fullsize/Cytokeratin-8-18-Antibody-SPM141-Immunohistochemistry-Paraffin-NBP2-44926-img0001.jpg "Immunohistochemistry-Paraffin: Cytokeratin 8/18 Antibody (SPM141) [NBP2-44926] - Human Lung Carcinoma stained with Cytokeratin 8/18 Monoclonal Antibody (SPM141).")
![Protein Array: S100A1 Antibody (S100A1/1942) [NBP2-59615] - containing more than 19,000 full-length human proteins. Z- and S- Score: The Z-score represents the strength of a signal that an antibody (in combination with a fluorescently-tagged anti-IgG secondary) produces when binding to a particular protein on the HuProt array. Z-scores are described in units of standard deviations above the mean value of all signals generated on that array. If targets on HuProt are arranged in descending order of the Z-score, the S-score is the difference between the Z-score. S-score therefore represents the relative target specificity of an Ab to its intended target. An Ab is considered to specific to its intended target, if the Ab has an S-score of at least 2.5. For example, if Ab binds to protein X with a Z-score of 43 and to protein Y with a Z-score of 14, then the S-score for the binding of that Ab to protein X is equal to 29](http://images.novusbio.com/fullsize/S100A1-Antibody-S100A1-1942-Protein-Array-NBP2-59615-img0003.jpg "Protein Array: S100A1 Antibody (S100A1/1942) [NBP2-59615] - containing more than 19,000 full-length human proteins. Z- and S- Score: The Z-score represents the strength of a signal that an antibody (in combination with a fluorescently-tagged anti-IgG secondary) produces when binding to a particular protein on the HuProt array. Z-scores are described in units of standard deviations above the mean value of all signals generated on that array. If targets on HuProt are arranged in descending order of the Z-score, the S-score is the difference between the Z-score. S-score therefore represents the relative target specificity of an Ab to its intended target. An Ab is considered to specific to its intended target, if the Ab has an S-score of at least 2.5. For example, if Ab binds to protein X with a Z-score of 43 and to protein Y with a Z-score of 14, then the S-score for the binding of that Ab to protein X is equal to 29")
![Immunohistochemistry-Paraffin: S100A1 Antibody (S100A1/1942) [NBP2-59615] - Formalin-fixed, paraffin-embedded human Melanoma stained with S100A1 Antibody (S100A1/1942).](http://images.novusbio.com/fullsize/S100A1-Antibody-S100A1-1942-Immunohistochemistry-Paraffin-NBP2-59615-img0004.jpg)
![Immunohistochemistry-Paraffin: S100A1 Antibody (S100A1/1942) [NBP2-59615] - Formalin-fixed, paraffin-embedded human Melanoma stained with S100A1 Mouse Monoclonal Antibody (S100A1/1942)](http://images.novusbio.com/fullsize/S100A1-Antibody-S100A1-1942-Immunohistochemistry-Paraffin-NBP2-59615-img0001.jpg)
![Western Blot: Cytokeratin 19 Antibody (A53-B/A2.26 + BA17) [NBP2-34272] - Western Blot Analysis of HepG2 cell lysate Cytokeratin 19 Antibody (A53-B/A2.26 + BA17).](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-A53-B-A2-26-+-BA17-Western-Blot-NBP2-34272-img0002.jpg "Western Blot: Cytokeratin 19 Antibody (A53-B/A2.26 + BA17) [NBP2-34272] - Western Blot Analysis of HepG2 cell lysate Cytokeratin 19 Antibody (A53-B/A2.26 + BA17).")
![Immunohistochemistry: Cytokeratin 19 Antibody (A53-B/A2.26 + BA17) [NBP2-34272] - Human breast cancer tissue stained with CK19 antibody. IHC-Fr image submitted by a verified customer review.. Using the DyLight 405 format of this antibody.](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-A53-B-A2-26-+-BA17-Immunohistochemistry-NBP2-34272-img0003.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (A53-B/A2.26 + BA17) [NBP2-34272] - Formalin-fixed, paraffin-embedded human colon carcinoma stained with Cytokeratin 19 MAb (A53-B/A2.26 + BA17)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-A53-B-A2-26-+-BA17-Immunohistochemistry-Paraffin-NBP2-34272-img0001.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 8/18 Antibody (B22.1/B23.1) [NBP2-44928] - Human Lung Carcinoma stained with Cytokeratin 8/18 Monoclonal Antibody (B22.1 + B23.1).](http://images.novusbio.com/fullsize/Cytokeratin-8-18-Antibody-B22-1-B23-1-Immunohistochemistry-Paraffin-NBP2-44928-img0001.jpg "Immunohistochemistry-Paraffin: Cytokeratin 8/18 Antibody (B22.1/B23.1) [NBP2-44928] - Human Lung Carcinoma stained with Cytokeratin 8/18 Monoclonal Antibody (B22.1 + B23.1).")
![Western Blot: Protein Phosphatase 1C gamma Antibody [NB110-40551] - Whole cell lysate (50 mcg for WB; 1 mg for IP, 20% of IP loaded) from HeLa cells. NB110-40551 used for WB at 0.1 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 3 mcg/mg lysate (B). PPP1CB was also immunoprecipitated by NB110-40551.](http://images.novusbio.com/fullsize/Protein-Phosphatase-1C-gamma-Antibody-Western-Blot-NB110-40551-img0002.jpg "Western Blot: Protein Phosphatase 1C gamma Antibody [NB110-40551] - Whole cell lysate (50 mcg for WB; 1 mg for IP, 20% of IP loaded) from HeLa cells. NB110-40551 used for WB at 0.1 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 3 mcg/mg lysate (B). PPP1CB was also immunoprecipitated by NB110-40551.")
![Immunohistochemistry-Paraffin: Protein Phosphatase 1C gamma Antibody [NB110-40551] - Human breast carcinoma. Antibody: Affinity purified rabbit anti- PPP1CC used at a dilution of 1:1,000 (1ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/Protein-Phosphatase-1C-gamma-Antibody-Immunohistochemistry-Paraffin-NB110-40551-img0010.jpg)
![Western Blot: HspA4 Antibody [NBP2-16898] - Sample (30 ug of whole cell lysate) A: Raji B: K562 5% SDS PAGE gel, diluted at 1:1000.](http://images.novusbio.com/fullsize/HspA4-Antibody-Western-Blot-NBP2-16898-img0002.jpg "Western Blot: HspA4 Antibody [NBP2-16898] - Sample (30 ug of whole cell lysate) A: Raji B: K562 5% SDS PAGE gel, diluted at 1:1000.")
![Immunohistochemistry-Paraffin: HspA4 Antibody [NBP2-16898] - Immunohistochemical analysis of paraffin-embedded Hepatoma, using antibody at 1:500 dilution.](http://images.novusbio.com/fullsize/HspA4-Antibody-Immunohistochemistry-Paraffin-NBP2-16898-img0003.jpg)
![Whole cell extract (30 ug) was separated by 7.5% SDS-PAGE, and the membrane was blotted with HSPA4 antibody [N3C2], Internal (NBP2-16898) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-16898_rabbit-polyclonal-hspa4-antibody-western-blot-2611202518342613.jpg)
![Western Blot: KANK2 Antibody [NB100-68217] - Detection of Human KANK2/SIP on HeLa whole cell lysate using NB100-68217. KANK2/SIP was also immunoprecipitated by rabbit anti-KANK2/SIP antibody NB100-68218.](http://images.novusbio.com/fullsize/KANK2-Antibody-Western-Blot-NB100-68217-img0001.jpg "<b>Independent Antibodies Validation. </b>Western Blot: KANK2 Antibody [NB100-68217] - Detection of Human KANK2/SIP on HeLa whole cell lysate using NB100-68217. KANK2/SIP was also immunoprecipitated by rabbit anti-KANK2/SIP antibody NB100-68218.")
![<b>Independent Antibodies Validation. </b>Immunohistochemistry: KANK2 Antibody [NB100-68217] - Sample: FFPE section of human prostate carcinoma. Antibody: Affinity purified rabbit anti- KANK2/SIP used at a dilution of 1:1,000 (1ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/KANK2-Antibody-Immunohistochemistry-NB100-68217-img0003.jpg)
![Immunohistochemistry-Paraffin: EMMPRIN/CD147 Antibody (8D6) [NBP2-33015] - Formalin-fixed, paraffin-embedded human Renal Cell Carcinoma stained with CD147 Monoclonal Antibody (8D6).](http://images.novusbio.com/fullsize/EMMPRIN-CD147-Antibody-8D6-Immunohistochemistry-Paraffin-NBP2-33015-img0001.jpg "Immunohistochemistry-Paraffin: EMMPRIN/CD147 Antibody (8D6) [NBP2-33015] - Formalin-fixed, paraffin-embedded human Renal Cell Carcinoma stained with CD147 Monoclonal Antibody (8D6).")
![Western Blot: Bcl-2 Antibody (BCL2/782 + BCL2/796) [NBP2-44785] - Western Blot Analysis of human MCF-7 cell lysate using Bcl-2 Antibody (BCL2/782 + BCL2/796).](http://images.novusbio.com/fullsize/Bcl-2-Antibody-BCL2-782-+-BCL2-796-Western-Blot-NBP2-44785-img0003.jpg "Western Blot: Bcl-2 Antibody (BCL2/782 + BCL2/796) [NBP2-44785] - Western Blot Analysis of human MCF-7 cell lysate using Bcl-2 Antibody (BCL2/782 + BCL2/796).")
![Immunohistochemistry-Paraffin: Bcl-2 Antibody (BCL2/782 + BCL2/796) [NBP2-44785] - Human non-Hodgkin's Lymphoma stained with Bcl-2 Monoclonal Antibody (BCL2/782 + BCL2/796).](http://images.novusbio.com/fullsize/Bcl-2-Antibody-BCL2-782-+-BCL2-796-Immunohistochemistry-Paraffin-NBP2-44785-img0002.jpg)
![Immunohistochemistry-Paraffin: Bcl-2 Antibody (BCL2/782 + BCL2/796) [NBP2-44785] - Human Melanoma stained with Bcl-2 Monoclonal Antibody (BCL2/782 + BCL2/796).](http://images.novusbio.com/fullsize/Bcl-2-Antibody-BCL2-782-+-BCL2-796-Immunohistochemistry-Paraffin-NBP2-44785-img0001.jpg)